Accuray, Inc. (ARAY)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$0.27+0.30%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ARAY
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 401.9 | 401.9 | 458.5 | 446.6 | 447.6 | 429.9 | 396.3 | 382.9 | 418.8 | 404.9 | 383.4 | 398.8 | 379.8 | 369.4 | 316.0 | 409.2 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | 383.4 | 398.8 | 379.8 | 369.4 | 316.0 | 409.2 |
| Cost of Revenues | 290.5 | 290.5 | 311.5 | 303.6 | 293.6 | 270.0 | 236.8 | 233.2 | 256.1 | 243.2 | 242.1 | 240.1 | 234.4 | 226.6 | 218.3 | 272.0 |
| Gross Profit | 111.5 | 111.5 | 147.0 | 142.9 | 154.0 | 160.0 | 159.5 | 149.7 | 162.7 | 161.7 | 141.3 | 158.7 | 145.4 | 142.8 | 97.6 | 137.3 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 37.8 | 37.8 | 47.9 | 49.7 | 57.1 | 57.8 | 52.7 | 49.8 | 56.5 | 57.3 | 49.9 | 56.7 | 55.8 | 53.7 | 66.2 | 81.3 |
| Operating Income | (26.4) | (26.4) | 7.8 | 0.5 | 2.4 | 8.1 | 22.2 | 12.5 | 0.6 | (3.8) | (9.8) | (4.9) | (19.2) | (18.1) | (80.7) | (56.2) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 32.9 | 13.0 | 11.6 | 10.6 | 8.1 | 16.9 | 18.1 | — | — | — | — | — | — | — | — |
| Interest & Investment Income | 0.8 | 0.8 | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.4 |
| Asset Writedown | — | 2.4 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (47.2) | 1.1 | (11.8) | (6.8) | (2.0) | (4.6) | 5.7 | (14.3) | (23.0) | (28.5) | (23.2) | (37.8) | (32.4) | (93.8) | (68.8) |
| Income Tax Expense | 1.9 | 1.9 | 2.7 | 3.7 | 2.5 | 3.3 | 1.8 | 1.9 | 2.1 | 0.9 | 1.0 | 2.3 | 2.4 | 3.1 | 3.6 | 2.6 |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | — | — | — | — | — | 13.3 | — | (6.4) |
| Net Income | (49.2) | (49.2) | (1.6) | (15.5) | (9.3) | (5.3) | (6.3) | 3.8 | (16.4) | (23.9) | (29.6) | (25.5) | (40.2) | (35.4) | (116.5) | (78.5) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (0.40) | (0.02) | (0.16) | (0.10) | (0.06) | (0.07) | 0.04 | — | — | — | — | — | — | — | (1.02) |
| Diluted EPS | — | — | (0.02) | (0.16) | (0.10) | (0.06) | (0.07) | 0.04 | — | — | — | — | — | — | — | (1.02) |
| Basic Weighted Avg Shares | — | 122.6 | 102.8 | 98.3 | 94.9 | 92.1 | 92.0 | 89.9 | — | — | — | — | — | — | 73.3 | 70.9 |
| Diluted Weighted Avg Shares | — | — | 102.8 | 98.3 | 94.9 | 92.1 | 92.0 | 90.6 | — | — | — | — | — | — | 73.3 | 70.9 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (18.5) | 14.0 | 6.4 | 6.9 | 13.7 | 28.6 | 20.1 | 11.1 | 5.9 | 8.2 | 13.4 | 0.3 | 2.4 | (55.1) | (23.6) |
| EBIT | (26.4) | (26.4) | 7.8 | 0.5 | 2.4 | 8.1 | 22.2 | 12.5 | 0.6 | (3.8) | (9.8) | (4.9) | (19.2) | (18.1) | (80.7) | (56.2) |
| Effective Tax Rate | — | — | — | — | -36.7% | -167.1% | -38.4% | 32.7% | -14.5% | -3.8% | -3.6% | -10.1% | -6.4% | -9.5% | -3.8% | -3.8% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.